Developing tools to improve drug development for various diseases
A Translational Center for Barrier MPS
['FUNDING_OTHER'] · UNIVERSITY OF ROCHESTER · NIH-11005753
This study is working on new tools to help create better medicines by understanding how the body's barriers affect diseases like brain disorders, autoimmune issues, and infections, so that patients can have more effective treatment options in the future.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ROCHESTER (nih funded) |
| Locations | 1 site (ROCHESTER, UNITED STATES) |
| Trial ID | NIH-11005753 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative drug development tools that assess how barrier functions in the body affect diseases, injuries, and infections. The project aims to develop and validate these tools for conditions such as central nervous system disorders, autoimmune diseases, and sepsis. By utilizing advanced models and technologies, the research team will ensure that these tools are reliable and effective for clinical use. Patients may benefit from improved treatment options as these tools help streamline the drug development process.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from central nervous system disorders, autoimmune diseases, or those at risk of sepsis.
Not a fit: Patients with conditions unrelated to the focus areas of this research may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with serious conditions like autoimmune diseases and central nervous system disorders.
How similar studies have performed: Previous research has shown promise in developing drug development tools for similar conditions, indicating a potential for success in this approach.
Where this research is happening
ROCHESTER, UNITED STATES
- UNIVERSITY OF ROCHESTER — ROCHESTER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MCGRATH, JAMES L — UNIVERSITY OF ROCHESTER
- Study coordinator: MCGRATH, JAMES L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Autoimmune Diseases, autoimmune disorder, autoimmunity disease